Vitamin D receptor gene polymorphisms and breast cancer risk

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5472-5481

  Guy, Michelle ^a   Lowe, Lorraine C ^a   Bretherton Watt, Deborah ^a   Mansi, Janine L ^a   Peckitt, Clare ^b   Bliss, Judith ^b   Wilson, Rosalind Given ^c   Thomas, Valerie ^c   Colston, Kay W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; STEROID HORMONE; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR GENE; RETROSPECTIVE STUDY; VDR GENE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RESTRICTION MAPPING; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 4143049163     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0206     Document Type: Article

References (51)

1. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000;321(7261): 624-8.
2. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2(3):133-40.
3. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis (Lond) 2000;21(3):427-33.
4. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989;1(8631): 188-91.
5. Chouvet C, Vicard E, Devonec M, Saez S. 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 1986;24(1):373-6.
6. Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. J Cell Physiol 1989;138(3):611-6.
7. James SY, Mackay AG, Colston KW. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 1995;14(3):391-4.
8. Welsh JE. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 1995;72(11-12): 537-45.
9. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9(1):45-59.
10. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11(12):1850-5.
11. Ingles SA, Haile R, Henderson B, Kolonel L, Coetzee G. Association of vitamin D receptor genetic polymorphism with breast cancer risk in African-American and Hispanic women. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: chemistry, biology and clinical applications of the steroid hormone. Riverside, CA: University of California; 1997. p. 813-4.
12. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992;89(15):6665-9.
13. Faraco JH, Morrison NA, Baker A, Shine J, Frossard PM. ApaI dimorphism at the human vitamin D receptor gene locus [abstr]. Nucleic Acids Res 1989;17(5):2150.
14. Hustmyer FG, DeLuca HF, Peacock M. ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians [abstr]. Hum Mol Genet 1993;2(4):487.
15. Ingles SA, Haile RW, Henderson BE, et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomark Prev 1997;6(2):93-8.
16. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature (Lond) 1994;367(6460):284-7.
17. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996;56(18):4108-10.
18. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (Bethesda) 1997;89(2):166-70.
19. Curran JE, Vaughan T, Weinstein SR, Morrison NA, Griffiths LR. Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 1999;83(6):723-6.
20. Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism, Cancer Res 1999;59(10):2332-4.
21. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11(12):1841-9.
22. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK population. Br J Cancer 2001;85(2): 171-5.
23. Whitfield KG, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001;177(1-2):145-59.
24. StataCorp. Stata statistical software: release 7.0. College Station, TX: Stata Corporation; 2001.
25. Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 1998;13(1):31-5.
26. Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3′-end region polymorphisms. J Bone Miner Res 1998;13(6):925-30.
27. Yamagata Z, Zhang Y, Asaka A, Kanamori M, Fukutomi T. Association of breast cancer with vitamin D receptor gene [Abstract]. Am J Hum Genet 1997;61.
28. Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, Pacini P. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncology Res 1998;10(1):43-6.
29. Dunning AM, McBride S, Gregory J, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis (Lond) 1999;20(11):2131-5.
30. Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomark Prev 2002;11(11):1503-4.
31. Gong G, Stern HS, Cheng SC, et al. The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporosis Int 1999;9(1):55-64.
32. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996;276(17):1404-8.
33. Janowsky EC, Lester GE, Weinberg CR, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr 1999;2(3):283-91.
34. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 1997;82(1):118-22.
35. Hansen CM, Hamberg KJ, Binderup E, Binderup L. Seocalcitol (EB1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Design 2000;6(7):803-28.
36. Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997;12(6):915-21.
37. Colin EM, Weel AE, Uitterlinden AG, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxy-vitamin D3. Clin Endocrinol 2000;52(2):211-6.
38. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000;14(3):401-20.
39. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998;13(11): 1691-9.
40. Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomark Prev 2003;12(1):23-7.
41. Verbeek W, Gombart AF, Shiohara M, Campbell M, Koeffler HP. Vitamin D Receptor: No evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem Biophys Res Comm 1997;238(1):77-80.
42. Mocharla H, Butch AW, Pappas AA, et al. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 1997;12(5):726-33.
43. Gross C, Musiol IM, Eccleshall TR, Malloy PJ, Feldman D. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Biochem Biophys Res Commun 1998;242(3):467-73.
44. Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta 1999;1453(3):311-20.
45. Carling T, Rastad J, Akerstrom G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998;83(7):2255-9.
46. Grzybowska EA, Wilczynska A, Siedlecki JA. Regulatory functions of 3′UTRs. Biochem Biophys Res Commun 2001;288(2):291-5.
47. Keaveney M, Parker MG, Gannon F. Identification of a functional role for the 3′ region of the human oestrogen receptor gene. J Mol Endocrinol 1993;10(2):143-52.
48. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995;20(11): 465-70.
49. Le H, Tanguay RL, Balasta ML, et al. Translation initiation factors eIF-iso4G and eIF-4B interact with the poly(A)-Binding protein and increase its RNA binding activity. J Biol Chem 1997;272(26):16247-55.
50. Deo RC, Bonanno JB, Sonenberg N, Burley SK. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell 1999;98(6): 835-45.
51. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22(2):203-17.